Beta Drugs Limited has acquired a 66.09% stake in Nivian Lifesciences, enhancing its presence in the rapidly growing IVF therapy market in India, which is valued at INR 1,500–1,700 crore.
Forbes contributors publish independent expert analyses and insights. Dr. Cheryl Robinson covers areas of leadership, pivoting and careers. IVF treatment imposes a severe mental and emotional toll, ...
Anti-Mullerian Hormone (AMH) is the current gold standard test, along with a fertility ultrasound scan for egg reserve.